Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 6 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
MEDIBAT from Braine-l'Alleud, company number BE0448812565, closed financial year 2025 with a result of € -172,791 after tax. For that financial year MEDIBAT recorded a gross margin of € -147,567 and equity of € 199,742. Compared with financial year 2024, the result moved from € 144,612 to € -172,791. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 10, 2026.
€ 199,742
▼ 46% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -172,791
▼ still € 144,612 profit in 2024
Profit after tax over the fiscal year.
€ 16,017
▼ 90% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 134,480.
People and assets in 2025
€ 3,640
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,277
▼ 27% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 1.6 million
▲ 136% vs 2024
€ 405,180 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 120
▼ € 52,994 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 13,909
▼ 56% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 94,655 | € 239,666 | € 260,104 | € -147,567 | ▼ € 407,672 |
| Profit after taxes | € -30,836 | € 62,297 | € 144,612 | € -172,791 | ▼ € 317,403 |
| Equity | € 165,624 | € 227,921 | € 372,533 | € 199,742 | ▼ 46% |
| Total debts | € 1,506,750 | € 986,262 | € 801,042 | € 2,050,619 | ▲ 156% |
| Cash | € 3,238 | € 48,517 | € 154,580 | € 16,017 | ▼ 90% |
| Land & buildings | € 977,175 | € 491,587 | € 547,438 | € 1,274,049 | ▲ 133% |
| Retained profit | € 100,363 | € 162,659 | € 307,271 | € 134,480 | ▼ 56% |
| Bank debt | € 1,290,222 | € 762,768 | € 669,792 | € 1,580,909 | ▲ 136% |
| Balance sheet total | € 1,702,278 | € 1,258,156 | € 1,254,640 | € 2,268,401 | ▲ 81% |
Key figures of MEDIBAT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to MEDIBAT?
What happened at MEDIBAT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 172,791 (▼ € 317,403 vs 2024). filed late Source: NBB ↗
- Jean-Marie Couet stepped down as director. NBB
- Vincent Couet stepped down as director. NBB
- Jean-Marie Couet became a director. NBB
- Vincent Couet became a director. NBB
- New establishment in Braine-l'Alleud. KBO
- Start of the company according to the CBE. KBO
In short
From € 30,836 loss in 2022 to € 172,791 loss in 2025.
Paid € 28,909 in corporate taxes since 2022.
Best year ever: 2024, with € 144,612 profit.
A new publication or filing at MEDIBAT? We notify you, reason included.
Follow MEDIBATDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
Jean-Marie Couet
Managing director
since 2017 · until 2023
Vincent Couet
Director
Also active at: AB-BROKERS, CHATEAU D'OR, AROUND, Parte, PARTE EXPERT, LES CRÉAS DE XAV, Antomax Air Conditionning, EMBOURIMMO +3 more
since 2017 · until 2023
Establishments
Establishment units
Physical locations of this company
Cl du Ch d'Abeiche 11
1420 Braine-l'Alleud
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0448.812.565
- VAT number
- BE 0448.812.565
- Registered office
- Cl du Ch d'Abeiche 11, 1420 Braine-l'Alleud
- Names & denominations
- MEDIBAT
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 10 December 1992
- Peppol
- Active · Active since 22 Dec 2025
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering